U.S. researchers confirm that prediabetes risk, presence can be identified using A1C test with same accuracy as other, less convenient tests.
Read More »Screen and Treat to Prevent Type 2
Object of meta-analysis to assess diagnostic accuracy of screening tests for prediabetes and efficacy of interventions (lifestyle or metformin) in preventing diabetes.
Read More »Can Metformin Prevent Colorectal Cancer for Type 2 Patients?
Meta-analysis found metformin therapy was associated with decreased risk for colorectal adenomas and colorectal cancer among T2 patients.
Read More »Prediabetes Tied to Smaller Bone Size
Insulin resistance is inversely and independently associated with bone size in young men without diabetes, according to a new study.
Read More »More on SGLT-2
CV data added to labels for treatments containing empagliflozin.
Read More »Altamash Shaikh Part 1, Diabetes in India
Dr. Altamash Shaikh talks with Diabetes in Control Associate Medical Editor Joy Pape at the 2016 AACE Meeting. In part 1 of this Exclusive Interview, Dr. Shaikh explains the current state of diabetes in India and the needs required to help this population to manage this condition.
Read More »Prediabetes Increases Risk for All-Cause Mortality
Study data show fasting glucose concentrations of at least 100 mg/dL (5.6 mmol/L) or an HbA1c of at least 5.7% (39 mmol/mol) were determining factors.
Read More »Treatment to Possibly Prevent Kidney Failure
Liraglutide, on top of stable renin angiotensin system (RAS)-inhibition, is associated with significant reduction in albuminuria among patients with type 2 diabetes and persistent microalbuminuria.
Read More »Large Doses of Insulin Increase Risk of Mortality for Type 2 Patients?
Study offers at least partial explanation for opposing findings between previous observational studies.
Read More »Low-dose Aspirin for Type 2 Patients?
Therapy shows neutral CV benefit, increases bleeding risk in type 2 diabetes.
Read More »